1623 Capital LLC Dexcom Inc Transaction History

1623 Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $301,331 - $588,968	4,432 Added 527.62%	5,272 $393,000
Q1 2022 May 13, 2022	SELL	$94.08 - $130.2 $30,481 - $42,184	-324 Reduced 27.84%	840 $430,000
Q4 2021 Feb 11, 2022	BUY	$129.87 - $162.82 $23,246 - $29,144	179 Added 18.17%	1,164 $625,000
Q2 2021 Aug 13, 2021	BUY	$80.99 - $107.93 $33,448 - $44,575	413 Added 72.2%	985 $421,000
Q1 2021 May 14, 2021	BUY	$84.79 - $104.74 $48,499 - $59,911	572 New	572 $206,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of 1623 Capital LLC, based on Form 13F filings with the SEC.

Stay updated on 1623 Capital LLC with notifications on news.